Royal Bank of Canada Lowers Lexeo Therapeutics (NASDAQ:LXEO) Price Target to $20.00
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective lowered by research analysts at Royal Bank of Canada from $24.00 to $20.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 401.25% […]
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective lowered by research analysts at Royal Bank of Canada from $24.00 to $20.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 401.25% […]
